Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis by Victoria Maksimova, Amanda R. Panfil

Get full text

The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine by Joshua J. Tu, Victoria Maksimova, Victoria Maksimova, Lee Ratner, Amanda R. Panfil, Amanda R. Panfil

Get full text

Dynamic Roles of RNA and RNA Epigenetics in HTLV-1 Biology by Emily M. King, Amanda R. Panfil

Get full text

CRISPR Genome Editing Applied to the Pathogenic Retrovirus HTLV-1 by Amanda R. Panfil, Amanda R. Panfil, Patrick L. Green, Patrick L. Green, Kristine E. Yoder, Kristine E. Yoder

Get full text

CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus by Amanda R. Panfil, Amanda R. Panfil, James A. London, Patrick L. Green, Patrick L. Green, Kristine E. Yoder, Kristine E. Yoder

Get full text

Novel perspectives on antisense transcription in HIV-1, HTLV-1, and HTLV-2 by Edward Lin, Amanda R. Panfil, Grace Sandel, Pooja Jain

Get full text

The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines in vitro and in vivo by Kyle Ernzen, Corrine Melvin, Lianbo Yu, Cameron Phelps, Stefan Niewiesk, Stefan Niewiesk, Patrick L. Green, Patrick L. Green, Amanda R. Panfil, Amanda R. Panfil

Get full text

HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models by Victoria Maksimova, Susan Smith, Jaideep Seth, Cameron Phelps, Stefan Niewiesk, Yorifumi Satou, Patrick L. Green, Patrick L. Green, Amanda R. Panfil, Amanda R. Panfil

Get full text

Upregulation of Neuropilin-1 Inhibits HTLV-1 Infection by Wesley Kendle, Kimson Hoang, Erica Korleski, Amanda R. Panfil, Nicholas Polakowski, Isabelle Lemasson

Get full text

Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5 by Amanda R. Panfil, Jacob Al-Saleem, Cory M. Howard, Nikoloz Shkriabai, Mamuka Kvaratskhelia, Patrick L. Green, Patrick L. Green

Get full text

HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development. by Victoria Maksimova, Tasha Wilkie, Susan Smith, Cameron Phelps, Corrine Melvin, Lianbo Yu, Stefan Niewiesk, Patrick L Green, Amanda R Panfil

Get full text

PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival by Amanda R. Panfil, Jacob Al-Saleem, Cory M. Howard, Jessica M. Mates, Jesse J. Kwiek, Robert A. Baiocchi, Patrick L. Green

Get full text

HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo by Michael P. Martinez, Xiaogang Cheng, Ancy Joseph, Jacob Al-Saleem, Amanda R. Panfil, Marilly Palettas, Wessel P. Dirksen, Lee Ratner, Patrick L. Green

Get full text

HBZ upregulates myoferlin expression to facilitate HTLV-1 infection. by Nicholas Polakowski, Md Abu Kawsar Sarker, Kimson Hoang, Georgina Boateng, Amanda W Rushing, Wesley Kendle, Claudine Pique, Patrick L Green, Amanda R Panfil, Isabelle Lemasson

Get full text

Retroviral b‐Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation by Julie Joseph, Thomas A. Premeaux, Daniel O. Pinto, Abhishek Rao, Shrobona Guha, Amanda R. Panfil, Alison J. Carey, Lishomwa C. Ndhlovu, Elke S. Bergmann‐Leitner, Pooja Jain

Get full text

HTLV‐1 infected T cells cause bone loss via small extracellular vesicles by Nitin Kumar Pokhrel, Amanda R. Panfil, Haniya Habib, Shamreethaa Seeniraj, Ancy Joseph, Daniel Rauch, Linda Cox, Robert Sprung, Petra Erdmann Gilmore, Qiang Zhang, Robert Reid Townsend, Lianbo Yu, Ayse Selen Yilmaz, Rajeev Aurora, William Park, Lee Ratner, Katherine N. Weilbaecher, Deborah J. Veis

Get full text